x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The BioHub: The Top Voices in Biotech

Max Brennan - Biotech HeadHunter

Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that"s shaping the future of biotechnology. Get ready for an immersive

science life sciences

All Episodes

00:26:37

Episode 83 - Joy Clark - Chief People Officer...

The BioHub: The Top Voices in Biotech ·

2025/10/29

Welcome to The BiohubJoy Clark, Chief People Officer at Worldwide Clinical Trials, joins The BioHub Podcast to talk about building belonging, leading with purpose, and driving health equity in clinical research. Joy shares her journey from high-growth tech to the CRO world, how Worldwide has cultivated a culture that’s 73% women, and why human-centered leadership matters more than ever.

en

00:24:07

Episode 82 - Heather Turner - CEO LB Pharmaceuticals

The BioHub: The Top Voices in Biotech ·

2025/10/28

We were thrilled to welcome, Heather Turner, CEO of LB Pharmaceuticals, onto The BioHub. Heather is a seasoned biotechnology executive with over 25 years of experience driving legal, operational, and strategic excellence across the biopharmaceutical industry. She currently serves as CEO of LB Pharmaceuticals, a clinical-stage company focused on innovative treatments for schizophrenia. Under her leadership, LB recently went public in a landmark IPO, marking a major milestone in the company’s growth

en

00:19:39

Episode 81 - Clarke Attwell - CEO Claris Biotherapeutics

The BioHub: The Top Voices in Biotech ·

2025/10/27

Today, we’re joined by Clarke Atwell, CEO of Claris Biotherapeutics — a company pioneering regenerative biologic therapies with a focus on transforming the field of ophthalmology.Under Clarke’s leadership, Claris has achieved a major milestone with its Series A financing, fueling the company’s mission to advance novel therapies designed to repair and restore vision at the cellular level, and are now in the process of going through there series B round. By combining cutting-edge biology with a deep

en

00:28:09

Episode 80 - Dr. Maurits Geerlings - CEO Nanocell

The BioHub: The Top Voices in Biotech ·

2025/10/23

Today I’m joined by Dr. Maurits Geerlings, President and CEOof NanoCell Therapeutics. Maurits is a true biotech entrepreneur — he’s co-founded and built multiple companies including Actinium Pharmaceuticals, Formula Pharmaceuticals, and Mirata Pharma — and now he’s on a mission to revolutionize in-vivo cell engineering. In this conversation, we dive into Maurits’ journey, the unique structure of NanoCell, the challenges and opportunities in cell therapy right now, and his bold vision for the future

en

00:33:55

Episode 79 - Amir Inamdar - Cybin Inc

The BioHub: The Top Voices in Biotech ·

2025/10/21

Amir Inamdar is the Chief Medical Officer at Cybin Inc., bringing more than 20 years of clinical medicine and drug-development experience. Prior to joining Cybin, Amir held senior roles in industry including Senior Medical Director for R&D Neurosciences at AstraZeneca, Medical Director at Takeda Development Centre Europe Ltd., and Director of Clinical Pharmacology & Discovery Medicine at GlaxoSmithKline. He's led global teams in advancing novel therapies across indications such as

en

00:25:24

Episode 78 - Dena House - CPO Adverum

The BioHub: The Top Voices in Biotech ·

2025/10/14

Today I’m joined by Dena House - Chief People Officer atAdverum Biotechnologies.Dena’s career has spanned some of the world’s leading life sciences companies, from Nikon Precision to Myriad Genetics, but what stands out is her passion for building strong, intentional culture in complex organizations.At Adverum, she was brought in with a clear mission: buildthe kind of people-first culture that can power innovation, resilience, and long-term growth, even in one of biotech’s toughest markets.We talk

en

00:18:14

Episode 77 - Baruch Harris - COO of Pretzel Therapeutics

The BioHub: The Top Voices in Biotech ·

2025/10/09

We were delighted to welcome Baruch Harris, Chief Operating Officer at Pretzel Therapeutics, a company dedicated to translating mitochondrial biology into transformative therapies. Dr. Harris’s journey spans from rigorous scientific roots to strategic leadership — he holds a Ph.D. in Biochemistry and Molecular Biology from UCSF and a degree in Biophysics from Brown University. Before joining Pretzel, he led business development, operations, and fundraising efforts at companies including ROME

en

00:25:31

Episode 76 - Abid Ansari - CFO of General Oncology

The BioHub: The Top Voices in Biotech ·

2025/10/08

Welcome back to another episode of The BioHub, we were delighted to welcome on Abid Ansari, Chief Financial Officer at General Oncology, a clinical-stage biopharma company focused on first-in-class therapies for metastatic cancer. With more than two decades of experience in the biotechnology and life sciences sectors, Abid has built his reputation as a strategic finance executive who bridges capital, innovation, and growth. Over his career, he’s led major capital raises — including a $153 million

en

00:32:22

Episode 75 - Paul Song - CEO of NKGen

The BioHub: The Top Voices in Biotech ·

2025/10/07

I’m joined by Dr. Paul Song, Chairman & CEO of NKGen Biotech.Paul has led across biotech, from CMO at NKGEN to co-founding Fuse Biotherapeutics and since 2022 he’s been driving NKGen’s mission to harness natural killer cells through their proprietary SNK platform for neurodegenerative diseases and cancer.In this episode, we dive into his decision to return and lead NKGen, the science behind the SNK platform, the company’s recent SPAC merger and NASDAQ listing, and his perspective on building

en

00:29:34

Episode 74 - Roy Maute - CEO of Pheast Therapeutics

The BioHub: The Top Voices in Biotech ·

2025/09/30

On this episode we had the pleasure of featuring Roy Maute of Pheast Therapeutics.Pheast are unleashing the power of macrophages in oncology, starting in advanced solid tumours & Ovarian Cancer. Their pipeline consists of novel innate immune checkpoint inhibitors (incl. Anti-CD24), based on research out of Irv Weissman's lab at Stanford. In this episode we cover the inspiration behind Roy's career in oncology R&D & the origins of Pheast's name & platform, before moving

en

00:39:35

Episode 73 - Tatiana Novobrantseva - CSO of NextPoint...

The BioHub: The Top Voices in Biotech ·

2025/09/30

Today, we're joined by Dr. Tatiana Novobrantseva, the Chief Scientific Officer at NextPoint Therapeutics, a clinical-stage biotech company pioneering precision immuno-oncology therapies targeting the novel HHLA2 (B7-H7) pathway.Tatiana brings over two decades of expertise in immunology, cancer, immuno-oncology, autoimmunity, and fibrosis. She co-founded Verseau Therapeutics in 2017, serving as CSO and advancing novel immunotherapies that stimulate macrophage repolarization to initiate

en

00:26:01

Episode 72 - Nick Manusos - CEO of Kenai Therapeutics

The BioHub: The Top Voices in Biotech ·

2025/09/25

Welcome back to another episode of The BioHub, we weredelighted to welcome on Nick Manusos, the CEO of Kenai Therapeutics, a pioneering biotech company developing neuron replacement therapies for neurological disorders. Nick’s journey spans decades of innovation and leadership—from senior roles at global pharma giants like Baxter, Takeda, and Abbott, to founding and leading cutting-edge startups like Iota Biosciences and Opsis Therapeutics. Under his guidance, Kenai Therapeutics has secured

en

00:51:44

Episode 71 - Punit Dhillon - CEO of Skye Bioscience

The BioHub: The Top Voices in Biotech ·

2025/09/24

Today’s guest is someone who’s seen biotech from both sidesof the table—first as an investor, and now as a builder. I’m joined by Punit Dhillon, CEO of Skye Bioscience, wherehe’s leading one of the most exciting stories in metabolic health.Punit started Skye as employee number one and has sincebuilt it into a clinical-stage company with one first-in-class programs and backing from major life science investors like 5AM and Versant. With a background in finance and business development—and a career

en

00:27:35

Episode 70 - Paula Soteropoulos

The BioHub: The Top Voices in Biotech ·

2025/09/24

We were delighted to welcome Paula Soteropoulos, Chairman of the Board at Ensoma and Venture Partner at 5am Ventures, onto The BioHub. Paula is a seasoned leader whose career spans some of the most influential companies in the industry and she's played a pivotal role in shaping the biotechlandscape over the past few decades She began her journey at Genzyme, where she spent nearly two decades helping bring transformative therapies to patients. She later took on leadership roles at Moderna during

en

00:33:59

Episode 69 - Nolan Townsend - CEO of Lexeo Therapeutics

The BioHub: The Top Voices in Biotech ·

2025/09/18

Welcome back to another episode of The BioHub, we were thrilled to welcome on Nolan Townsend, CEO of Lexeo Therapeutics.Nolan has been at the helm of Lexeo since January 2020, leading a clinical-stage genetic medicine company aiming to transform treatment for genetically-defined cardiovascular diseases and APOE4-associated Alzheimer’s disease. Under his leadership, Lexeo has built a pipeline of therapies rooted in breakthrough science, partnered with prominent academic institutions like Weill

en

00:31:12

Episode 68 – Stefan Lutz – Codexis

The BioHub: The Top Voices in Biotech ·

2025/09/16

Welcome to The BioHub podcast, where we interview the top minds from across the Biotech and Pharma industry.I’m joined by Dr. Stefan Lutz, SVP of Research at Codexis—a leader in enzyme engineering and the force behind some of the most exciting advancements in RNA manufacturing.Stefan’s journey spans academia and industry, from chairing the Chemistry Department at Emory University to now driving innovation at Codexis. He and his team are helping solve some of biotech’s biggest challenges—from

en

00:21:30

Episode 67 - Micah Mackison - CEO of Vico Therapeutics

The BioHub: The Top Voices in Biotech ·

2025/09/16

Thanks for tuning into another episode of The BioHub, we were delighted to welcome on Micah Mackison who serves as the Chief Executive Officer of Vico Therapeutics, a company blazing trails in genetic neurology with RNA-based medicines. Since taking the helm in August 2022, Micah has been leading Vico’s drive to translate novel oligonucleotide RNA-modulating therapies from the lab into clinical trials, particularly in disorders like Huntington’s disease and spinocerebellar ataxia. Before Vico, Micah

en

00:27:51

Episode 66 - Andy Parker - CEO of Step Pharma

The BioHub: The Top Voices in Biotech ·

2025/09/09

Welcome to The BioHub podcast, where we interview the top minds from across the Biotech and Pharma industry.Today I’m joined by Andy Parker, the CEO of Step Pharma.Andy has spent over two decades in biotech and pharma,holding senior leadership roles at companies like AstraZeneca, Shire and Zealand Pharma and even spending time on the VC side at Eclosion. Since 2019, he’s been leading Step Pharma, a companydeveloping first-in-class CTPS1 inhibitors, with their lead program now in the clinic for

en

00:27:41

Episode 65 - Robert Ross - CEO of Clasp Therapeutics

The BioHub: The Top Voices in Biotech ·

2025/09/04

We were delighted to welcome Robert Ross, Chief Executive Officer at Clasp Therapeutics, onto The BioHub. Clasp Therapeutics are a pioneering biotech company spearheading the next generation of T-cell engager therapies. Founded in 2024 and backed by a successful $150 million Series A round with top tier investors, Clasp stands out for its novel approach in delivering off-the-shelf, bispecific T‐cell engagers that narrowly target cancer-driving mutations while sparing healthy tissues. Dr. Ross brings

en

00:29:33

Episode 64 - Kristof Vercruysse - CEO of TargED...

The BioHub: The Top Voices in Biotech ·

2025/08/28

Welcome to The BioHub podcast, where we interview the top minds from across the Biotech and Pharma industry.On this episode we were joined by Kristof Vercruysse, CEO of TargED Biopharmaceuticals, an Utrecht-based biotech who're developing a novel Targeted Enzyme Delivery approach to Thrombolysis. On this episode, we discuss the current standard of care in indications such as TTP & Acute Ischemic Stroke and why TargED's platform represents a potential paradigm-shift for patients.

en

108 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter